NCT05440786: CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
- State
- Under way
- Phase
- Phase 2
- People
- 46 taking part
- Started
- 20 Sep 2022
- Primary completion
- 15 Jan 2025
- Arms
- Abemaciclib + Irinotecan +Temozolomide
- Results
- Posted on the registry
- 1 Jul 2022: Trial registered
- 20 Sep 2022: Trial started
- 12 Mar 2026: Trial results posted